Skip to main content

Evorel

Important Safety Information regarding Evorel 25, 50, 75 and 100 Transdermal Patches

If you’re starting Evorel, you may have questions about how to use it and what to expect. This guide explains your treatment, how to use it safely, and when to speak to your clinical team.

What you need to know

Evorel is an oestrogen-only hormone replacement therapy (HRT), treatment that replaces hormones that fall during menopause. The patches release estradiol, a form of oestrogen, through your skin into your bloodstream.
​

This guide covers Evorel 25, 50, 75, and 100 patches. Change your patch twice a week on your usual change days. If you still have your womb, you must also use a separate progestogen, a hormone that protects your womb lining, as prescribed.

Always follow your prescription and read the patient information leaflet supplied with your treatment.
​

What’s in your treatment?

Evorel patches are an oestrogen-only hormone replacement therapy (HRT). They are adhesive patches that you stick on your skin. Each patch contains the body-identical hormone estradiol, which is steadily released through the skin (transdermal route) into your bloodstream over several days.
​

What is it used for?

Evorel is used to relieve the symptoms of menopause, such as hot flushes, night sweats, mood swings, and vaginal dryness. The 50mcg, 75mcg, and 100mcg strengths are also licensed for the prevention of osteoporosis (weakened bones that are more likely to break) in women after menopause at high risk of fractures.

Progestogen Requirement: If you have a womb, you must also take a separate progestogen to protect your womb lining. Speak to your clinical team for further advice if you are unsure.
​

How long does it take to work?

You may notice an improvement in symptoms within a few weeks, but it can take up to three months to adjust and feel the full benefit. Speak to your clinical team if symptoms aren’t improving.
​

How to use your treatment

Apply one patch to a clean, dry, and non-irritated area of skin on your lower abdomen or trunk, below the waistline. Do not apply the patch to your breasts or near your waistline where tight clothing might rub it off.
​

When and how to change a patch: Each patch is worn continuously and replaced twice a week (every 3 to four days). To help you remember, it is best to change your patch on the same two days each week, for example, every Monday and Thursday.

  • When you apply a new patch, choose a different spot of skin. You should wait at least one week before applying a patch to the same site again.

  • Evorel should remain in place during bathing and showering. Should a patch fall off during bathing or showering, you should wait until you’re dry and your body temperature returns to normal before applying a replacement patch to avoid potential excessive absorption of HRT.

  • Should a patch fall off at other times, it should be replaced immediately, but you should stick to your original change days.

  • You can use baby oil to help remove any gum/glue which may remain on the skin after patch removal.

As mentioned above, you should also take a cyclical progestogen for 12–14 days of each cycle if you still have a womb. Speak to your clinical team if you are unsure.
​

If you miss a dose

If you forget to change a patch, you should change it as soon as possible and apply the next one at the normal time on your original change days. However, if it is almost time for the next patch, you should skip the missed one and go back to your regular schedule. Only one patch should be applied at a time. There is an increased likelihood of unexpected bleeding and spotting when a patch is not replaced at the normal time. Always follow your prescribed instructions and check with your clinical team if you’re unsure.
​

Your dose and treatment plan

Therapy usually begins with one Evorel 50 patch. Treatment is usually started with the lowest effective dose and can be adjusted by your clinician after a few months depending on your response with the dose increased or decreased as necessary. Your clinician will aim to use the lowest effective dose for the shortest time needed to manage your symptoms, with regular reviews.
​

There are no special dosage requirements for older patients, although experience in treating women over 65 is limited. This medicine is not for use in children. Don’t cut a patch unless a specialist clinician has specifically instructed you to do so.
​

Contraception, pregnancy, and breastfeeding

This treatment isn’t contraception. You may still need contraception, including if it’s been less than 12 months since your last period or you’re under 50. Ask your clinical team for advice tailored to you.

If you become pregnant, stop treatment immediately and contact your clinician. This treatment isn’t indicated during breastfeeding.

Other important safety information

It is crucial to understand that if you have not had a hysterectomy (surgery to remove the womb) (i.e., you still have your womb), you must take a separate progestogen hormone (which protects the womb lining) alongside Evorel. This is typically prescribed for 12 to 14 days each month. This is a vital safety measure to protect the lining of your womb from the effects of oestrogen, which, when taken alone, can lead to a build-up of the lining (endometrial hyperplasia) and increase the risk of endometrial cancer (cancer of the womb lining).
​
​

Side effects and treatment risks

The most common side effect is skin irritation, redness, or itching at the site where the patch is applied. Other common side effects include headache, breast pain, nausea, and irregular bleeding. As a transdermal form of HRT, Evorel bypasses the liver and carries a lower risk of blood clots (venous thromboembolism) compared to other systemic forms of HRT, such as oral tablets or capsules. The other risks associated with systemic HRT, such as a small increased risk of breast cancer and stroke, still apply, although the overall risk remains low for most patients being treated. For a full list of side effects, please see the Patient Information Leaflet provided with your medication .
​
​

Reviews and ongoing clinical support

Your clinician will review your treatment after three months, then at least once a year. They’ll check your symptoms, side effects, any vaginal bleeding, your weight, and your blood pressure, and decide whether further tests are needed.

Examine your breasts regularly and attend routine screening appointments, including mammograms and cervical screening where appropriate. If you had menopause earlier than expected, discuss how this may affect the benefits and risks of HRT with your clinician.
​
​

When to stop treatment and seek medical help

Stop using Evorel and seek urgent medical advice if you develop:

  • Signs of a blood clot, such as painful swelling in a leg.

  • Swelling of your face, tongue, or throat, difficulty swallowing, or hives with difficulty breathing; possible signs of a severe allergic reaction.

  • Yellowing of your skin or eyes (jaundice).

  • A significant increase in your blood pressure.

  • A new migraine-type headache.

  • Pregnancy.

If you have difficulty breathing or another life-threatening symptom, call 999. Don’t wait for an email response.
​

For planned changes or stopping treatment, speak to your clinician. They may recommend reducing your dose gradually to help prevent menopausal symptoms from returning suddenly.
​
​

Conditions that need closer monitoring

Tell your clinical team if you have any of the following conditions, have had them before, or they worsened during pregnancy or previous hormone treatment. You may need closer monitoring because they can return or worsen during treatment.

  • Fibroids (non-cancerous growths in the womb) or endometriosis (tissue similar to the womb lining growing outside the womb)

  • Risk factors for blood clots

  • Risk factors for tumours affected by oestrogen, such as breast cancer in a close relative

  • High blood pressure

  • Liver conditions, including non-cancerous liver tumours

  • Diabetes, with or without blood vessel complications

  • Gallstones

  • Migraine or (severe) headache

  • Lupus (an immune-system condition).

  • A history of thickening of the womb lining

  • Epilepsy

  • Asthma

How to store your treatment

Do not store above 25ºC. Evorel should be kept away from children and pets. This applies to both new and used patches. Store in the original container.
​
​

When to speak to your clinical team

Contact your clinical team if you have questions about your prescribed schedule, side effects, symptoms that aren’t improving, or bleeding that concerns you. For non-urgent questions or to discuss your clinical plan, email [email protected].

Read the patient information leaflet supplied with your treatment for the full list of reasons not to use it, side effects, and precautions. This guide doesn’t replace that leaflet or your clinician’s instructions.
​
​

Frequently asked questions

Do I need another hormone alongside Evorel?

If you still have your womb, you must also use a separate progestogen to protect its lining. Your clinician will tell you which treatment to use and when to take it.

Can I change my dose myself?

No. Follow your prescription and speak to your clinical team before changing your dose or treatment schedule.

Is this treatment contraception?

No. Ask your clinical team whether you still need contraception and which options are suitable for you.


Storage instructions

Do not store above 25ºC. Evorel should be kept away from children and pets. This applies to both new and used patches. Store in the original container.

Further information:

If you have questions about your medication, wish to discuss alternative treatment plans, or need reassurance, our clinicians are available to provide expert advice and support. Just email us at [email protected].

Lastly, please read the Patient Information Leaflet linked below and included with your treatment for a full list of side effects, contraindications, and precautions.

Did this answer your question?